Shattuck Labs
Kelli joined Shattuck in January 2021 as Vice President of Quality. Prior to joining Shattuck, Kelli was the Executive Director of Quality Assurance at Liquidia Technologies, leading the quality department for GMP, GCP, and GLP operations. Kelli has over 17 years of experience in quality assurance, covering all aspects of the pharmaceutical product lifecycle. She received her Bachelor’s degree in Biological Engineering and a Master of Bioinformatics from North Carolina State University. She also holds a graduate certificate in Pharmaceutical & Medical Device Law & Compliance from Seton Hall Law School. She is a Certified Quality Manager/Operational Excellence (CMQOE) and a Certified Pharmaceutical GMP Professional (CPGMPP).
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.